-
5 spine devicemakers operating with a net loss in Q1
Spine devicemakers have shared their first quarter financial results this year in recent weeks. While many companies saw gains in sales, some also saw a net loss after accounting for operational costs. -
Aurora Spine's Q1 2024 sales grow 35.7%: 6 notes
Aurora Spine saw a 35.7% year-over-year increase in first quarter sales, according to financial results posted May 13. -
Meet the COOs of 5 top spine device companies
Leadership teams play a crucial role in running the top orthopedic and spine device companies nationwide. -
Medtronic in the headlines: 3 notes
Here are three updates on Medtronic that Becker's has reported on since April 24: -
Implanet earns FDA clearance for spine fixation system
Orthopedic technology company Implanet has earned FDA clearance for its hybrid fixation system, the Jazz Spinal System. -
Orthofix in the headlines: 5 notes
Here are five updates on Orthofix that Becker's has reported on since April 1: -
What 5 Alphatec execs were paid since 2021
Alphatec CEO Patrick Miles earned about $9.5 million in total compensation, according to the company's April 26 Securities and Exchange Commission proxy filing. -
Alphatec revenue grows 27% in Q1
Spine technology company Alphatec saw 27% revenue growth in the first quarter of 2024, reaching $138 million. -
6 medtech notes: Zimmer Biomet, Orthofix and more
From financial updates to new product developments, here are the key headlines from spine devicemakers since May 1. -
Smaller version of SI-Bone spine implant launched
A smaller version of SI-Bone's iFuse bedrock granite implant system was launched, and the first cases with it were completed, the medtech company said May 7. -
Globus Medical's Q1 sales soar 119.3%: 6 notes
Globus Medical saw a 119.3% year-over-year increase in first quarter sales, according to financial results posted May 7. -
Orthofix sees $36M net loss in Q1
Orthofix saw sales growth but a net loss in the first quarter of 2024, according to financial results posted May 7. -
ZygoFix earns FDA nod for lumbar fixation system
ZygoFix earned FDA clearance for its zLock device, the company said in a May 6 LinkedIn post. -
5 things to know about Stryker's orthopedics and spine president
Spencer Stiles is group president of orthopedics and spine at Stryker. -
Stryker vs. Zimmer Biomet vs. Johnson and Johnson: How they compare in Q1 2024
Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2024 and data on their orthopedic sales. -
OrthoPediatrics earns breakthrough designation for new scoliosis rod system
OrthoPediatrics earned the FDA's breakthrough designation for the eLLi growing rod system for scoliosis, the devicemaker said May 2. -
Zimmer Biomet sees robotic progress, executive exit: 5 Q1 earnings call notes
Zimmer Biomet is kicking off the year strong with first quarter sales growth and progress with its newer technologies, according to a May 2 earnings call. -
Zimmer Biomet sales rise 3.2% in Q1
Zimmer Biomet saw $1.89 billion in net sales in the first quarter of 2024, according to its 2024 financial report, published May 2. -
How Orthofix paid its current, former executives
Orthofix's new CEO Massimo Calafiore started his new role Jan. 8 with an annual base salary of $825,000, according to the company's April 29 proxy statement. -
How much 4 Globus Medical execs were paid since 2021
Globus Medical CEO Daniel Scavilla's salary rose to $4.6 million in 2023, according to the company's April 26 Securities and Exchange Commission proxy filing.
Page 4 of 195